CAS 184475-35-2
MF:C22H24ClFN4O3
It is a selective epidermal growth factor receptor tyrosine kinase (EGFR TK) inhibitor. It has antineoplastic activity, and has been approved for the treatment on non-small cell lung cancer (NSCLC).It has a higher affinity for ATP (adenosine triphosphate) binding site in the EGFR tyrosine kinase domain than ATP. Hence, it is known to inhibit the progression of endometrial cancer.
Description
CAS 184475-35-2 Product Information
| Product Name: | |
| Synonyms: | Iressa;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide;MFCD04307832;Irressat;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amin;N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chlor-4-fluorphenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]chinazolin-4-amin;N-(3-Chlor-4-fluorphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)chinazolin-4-amin;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;N-(3-chloro-4-fluorophényl)-7-méthoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;ZD-1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;ZD1839 |
| CAS NO: | 184475-35-2 |
| Molecular Weight: | 446.9 |
| Molecular Formula: | C22H24ClFN4O3 |
| Boiling Point: | 586.8±50.0 °C(Predicted) |
| Melting point: | 119-120°C |
| Density: | 1.322±0.06 g/cm3(Predicted) |
| Appearance: | white to beige powder |
| Purity: | >98% |
| Storage: | room temp |
Reviews
There are no reviews yet.